Texas Monthly profiles elite cyclist Lance Armstrong, the two-time Tour de France winner. "He doesn't use performance-enhancing drugs, he insists, no matter what his critics in the European press and elsewhere say. And yet the accusations keep coming," the magazine reports. The story depicts Lance's battle with testicular cancer, which had spread to his lungs and brain. The article examines how the use of EPO - a drug that saved Lance from cancer - and other dopes can enhance performance, and reveals how riders have always been a step ahead of the testers. A major finding is that "dopers enjoy a solidarity that is maintained by a code of silence."
This file is not available for digital download. IRE members may place an order by emailing email@example.com